Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
29,500
-50 (-0.17%)
At close: Sep 11, 2026

Next Biomedical Revenue

Next Biomedical had revenue of 4.94B KRW in the quarter ending June 30, 2026, with 24.28% growth. This brings the company's revenue in the last twelve months to 17.79B, up 46.25% year-over-year. In the year 2025, Next Biomedical had annual revenue of 16.48B with 72.67% growth.

Revenue (ttm)
17.79B
Revenue Growth
+46.25%
P/S Ratio
13.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
244.18B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202516.48B6.93B72.67%
Dec 31, 20249.54B4.66B95.46%
Dec 31, 20234.88B2.09B74.67%
Dec 31, 20222.80B527.74M23.28%
Dec 31, 20212.27B6.63M0.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
DRGEM109.45B
MEDIANA Co.,Ltd71.45B
JPI Healthcare46.86B
L&K Biomed39.94B
ASTERASYS Co.,Ltd39.61B
Hironic37.10B
SELVAS Healthcare31.69B
Remed27.05B
Revenue Rankings